ETFs Are Net Sellers of Charles River (CRL) on Wednesday

gurufocus.com · 2026-10-16

ETFs sold a net $21.8 million worth of Charles River Laboratories International (CRL) on Wednesday, Oct. 14. More funds traded the other way, with 18 ETFs buyin

TickrTrends take: Charles River Laboratories is currently rated as overvalued by TickrTrends valuation analysis within the Healthcare sector. The reported net selling pressure from ETFs on Wednesday may reflect broader concerns about the stock's current pricing relative to its fundamentals. Investors focused on valuation metrics should monitor whether this selling activity continues or whether the stock's price adjusts to align with its underlying business metrics.

Read the full story at gurufocus.com →